UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Efficacy trial of single-dose live oral cholera vaccine CVD 103-HgR in North Jakarta, Indonesia, a cholera-endemic area

Vaccine, 2000-05, Vol.18 (22), p.2399-2410

2000

Volltextzugriff (PDF)

Randomized, Double-Blind, Placebo-Controlled, Multicentered Trial of the Efficacy of a Single Dose of Live Oral Cholera Vaccine CVD 103-HgR in Preventing Cholera following Challenge with Vibrio cholerae O1 El Tor Inaba Three Months after Vaccination

Infection and Immunity, 1999-12, Vol.67 (12), p.6341-6345

1999

Volltextzugriff (PDF)

Safety and Immunogenicity of Intranasally Administered Inactivated Trivalent Virosome-Formulated Influenza Vaccine Containing Escherichia coli Heat-Labile Toxin as a Mucosal Adjuvant

The Journal of infectious diseases, 2000-03, Vol.181 (3), p.1129-1132

2000

Volltextzugriff (PDF)

Immunopotentiating reconstituted influenza virus virosome vaccine delivery system for immunization against hepatitis A

The Journal of clinical investigation, 1992-12, Vol.90 (6), p.2491-2495

1992

Volltextzugriff (PDF)

Immunogenicity of new virosome influenza vaccine in elderly people

The Lancet (British edition), 1994-07, Vol.344 (8916), p.160-163

1994

Volltextzugriff (PDF)

Mucosal and Systemic Immune Responses in Humans after Primary and Booster Immunizations with Orally Administered Invasive and Noninvasive Live Attenuated Bacteria

Infection and Immunity, 1999-07, Vol.67 (7), p.3680-3685

1999

Volltextzugriff (PDF)

Immunogenicity of trivalent subunit versus virosome-formulated influenza vaccines in geriatric patients

Vaccine, 1997-10, Vol.15 (15), p.1675-1679

1997

Volltextzugriff (PDF)

Immunogenicity of a 24-Valent Klebsiella Capsular Polysaccharide Vaccine and an Eight-Valent Pseudomonas O-Polysaccharide Conjugate Vaccine Administered to Victims of Acute Trauma

Clinical infectious diseases, 1996-07, Vol.23 (1), p.179-181

1996

Volltextzugriff (PDF)

Local and systemic immune responses to combined Vibrio cholerae CVD103-HgR and Salmonella typhi Ty21a live oral vaccines after primary immunization and reimmunization

Vaccine, 2000-07, Vol.18 (26), p.3031-3039

2000

Volltextzugriff (PDF)

Safety and Immunogenicity of Live Oral Cholera and Typhoid Vaccines Administered Alone or in Combination with Antimalarial Drugs, Oral Polio Vaccine, or Yellow Fever Vaccine

The Journal of infectious diseases, 1997-04, Vol.175 (4), p.871-875

1997

Volltextzugriff (PDF)

Safety and characterization of the immune response engendered by two combined measles, mumps and rubella vaccines

Vaccine, 1998-01, Vol.16 (2), p.298-304

1998

Volltextzugriff (PDF)

Phase I clinical trials of aroA aroD and aroA aroD htrA attenuated S. typhi vaccines; effect of formulation on safety and immunogenicity

Vaccine, 2000-02, Vol.18 (15), p.1473-1484

2000

Volltextzugriff (PDF)

Attenuated live cholera vaccine strain CVD 103-HgR elicits significantly higher serum vibriocidal antibody titers in persons of blood group O

Infection and Immunity, 1995-02, Vol.63 (2), p.707-709

1995

Volltextzugriff (PDF)

Vaccination promotes TH1-like inflammation and survival in chronic Pseudomonas aeruginosa pneumonia in rats

American journal of respiratory and critical care medicine, 1995-10, Vol.152 (4 Pt 1), p.1337-1346

1995

Volltextzugriff (PDF)

Elevated levels of maternal anti-tetanus toxin antibodies do not suppress the immune response to a Haemophilus influenzae type b polyribosylphosphate-tetanus toxoid conjugate vaccine

Bulletin of the World Health Organization, 2000-03, Vol.78 (3), p.364-371

2000

Volltextzugriff (PDF)

Synthesis and characterization of a polyvalent Escherichia coli O-polysaccharide-toxin A conjugate vaccine

Vaccine, 1995, Vol.13 (5), p.449-453

1995

Volltextzugriff (PDF)

A virosome vaccine antigen delivery system does not stimulate an antiphospholipid antibody response in humans

Vaccine, 1996-10, Vol.14 (14), p.1381-1383

1996

Volltextzugriff (PDF)

Seroepidemiology of Klebsiella bacteremic isolates and implications for vaccine development

Journal of Clinical Microbiology, 1986-04, Vol.23 (4), p.687-690

1986

Volltextzugriff (PDF)

Immunotherapy with human monoclonal antibodies. Fragment A specificity of polyclonal and monoclonal antibodies is crucial for full protection against tetanus toxin

The Journal of immunology (1950), 1993-07, Vol.151 (1), p.466-472

1993

Volltextzugriff (PDF)

Evaluation of a bivalent (CVD 103-HgR/CVD 111) live oral cholera vaccine in adult volunteers from the United States and Peru

Infection and Immunity, 1997-09, Vol.65 (9), p.3852-3856

1997

Volltextzugriff (PDF)

Randomized, double-blind placebo-controlled trial to evaluate the safety and immunogenicity of combined Salmonella typhi Ty21a and Vibrio cholerae CVD 103-HgR live oral vaccines

Infection and Immunity, 1996-04, Vol.64 (4), p.1454-1457

1996

Volltextzugriff (PDF)

Immunization with Pseudomonas aeruginosa vaccines and adjuvant can modulate the type of inflammatory response subsequent to infection

Infection and Immunity, 1994-08, Vol.62 (8), p.3146-3155

1994

Volltextzugriff (PDF)

Safety and immunogenicity of Salmonella typhi Ty21a vaccine in young Thai children

Infection and Immunity, 1993-03, Vol.61 (3), p.1149-1151

1993

Volltextzugriff (PDF)

Onset and duration of protective immunity in challenged volunteers after vaccination with live oral cholera vaccine CVD 103-HgR

The Journal of infectious diseases, 1992-10, Vol.166 (4), p.837

1992

Volltextzugriff (PDF)

Escherichia coli strains isolated from pigs with edema disease produce a variant of Shiga‐like toxin II

FEMS microbiology letters, 1987-09, Vol.44 (1), p.33-38

1987

Volltextzugriff (PDF)

1 – 25 von 254

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(223)
Mit Volltextzugriff
(184)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(157)
Life Sciences & Biomedicine
(154)
Humans
(126)
Biological And Medical Sciences
(120)
Immunology
(109)
Infectious Diseases
(98)
Microbiology
(97)
Fundamental And Applied Biological Sciences. Psychology
(76)
Animals
(70)
Bacteriology
(57)
Vaccines, Antisera, Therapeutical Immunoglobulins And Monoclonal Antibodies
(57)
Adult
(55)
Medical Sciences
(52)
Female
(51)
Bacterial Vaccines - Immunology
(48)
Vaccination
(48)
Immunization
(42)
Mice
(41)
Male
(40)
Polysaccharides, Bacterial - Immunology
(40)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Efficacy trial of single-dose live oral cholera vaccine CVD 103-HgR in North Jakarta, Indonesia, a cholera-endemic area

Randomized, Double-Blind, Placebo-Controlled, Multicentered Trial of the Efficacy of a Single Dose of Live Oral Cholera Vaccine CVD 103-HgR in Preventing Cholera following Challenge with Vibrio cholerae O1 El Tor Inaba Three Months after Vaccination

Safety and Immunogenicity of Intranasally Administered Inactivated Trivalent Virosome-Formulated Influenza Vaccine Containing Escherichia coli Heat-Labile Toxin as a Mucosal Adjuvant

Immunopotentiating reconstituted influenza virus virosome vaccine delivery system for immunization against hepatitis A

Immunogenicity of new virosome influenza vaccine in elderly people

Mucosal and Systemic Immune Responses in Humans after Primary and Booster Immunizations with Orally Administered Invasive and Noninvasive Live Attenuated Bacteria

Immunogenicity of trivalent subunit versus virosome-formulated influenza vaccines in geriatric patients

Immunogenicity of a 24-Valent Klebsiella Capsular Polysaccharide Vaccine and an Eight-Valent Pseudomonas O-Polysaccharide Conjugate Vaccine Administered to Victims of Acute Trauma

Local and systemic immune responses to combined Vibrio cholerae CVD103-HgR and Salmonella typhi Ty21a live oral vaccines after primary immunization and reimmunization

Safety and Immunogenicity of Live Oral Cholera and Typhoid Vaccines Administered Alone or in Combination with Antimalarial Drugs, Oral Polio Vaccine, or Yellow Fever Vaccine

Safety and characterization of the immune response engendered by two combined measles, mumps and rubella vaccines

Phase I clinical trials of aroA aroD and aroA aroD htrA attenuated S. typhi vaccines; effect of formulation on safety and immunogenicity

Attenuated live cholera vaccine strain CVD 103-HgR elicits significantly higher serum vibriocidal antibody titers in persons of blood group O

Vaccination promotes TH1-like inflammation and survival in chronic Pseudomonas aeruginosa pneumonia in rats

Elevated levels of maternal anti-tetanus toxin antibodies do not suppress the immune response to a Haemophilus influenzae type b polyribosylphosphate-tetanus toxoid conjugate vaccine

Synthesis and characterization of a polyvalent Escherichia coli O-polysaccharide-toxin A conjugate vaccine

A virosome vaccine antigen delivery system does not stimulate an antiphospholipid antibody response in humans

Seroepidemiology of Klebsiella bacteremic isolates and implications for vaccine development

Immunotherapy with human monoclonal antibodies. Fragment A specificity of polyclonal and monoclonal antibodies is crucial for full protection against tetanus toxin

Evaluation of a bivalent (CVD 103-HgR/CVD 111) live oral cholera vaccine in adult volunteers from the United States and Peru

Randomized, double-blind placebo-controlled trial to evaluate the safety and immunogenicity of combined Salmonella typhi Ty21a and Vibrio cholerae CVD 103-HgR live oral vaccines

Immunization with Pseudomonas aeruginosa vaccines and adjuvant can modulate the type of inflammatory response subsequent to infection

Safety and immunogenicity of Salmonella typhi Ty21a vaccine in young Thai children

Onset and duration of protective immunity in challenged volunteers after vaccination with live oral cholera vaccine CVD 103-HgR

Escherichia coli strains isolated from pigs with edema disease produce a variant of Shiga‐like toxin II

Suchergebnisse filtern